Author

Lucrecia Moreno

universidad CEU Cardenal Herrera - Cited by 1,685 - farmacologia

Biography

Dra Moreno is PhD in PHARMACY from the University of Valencia (1996), her doctoral thesis was awarded by the Real Academy of Medicine and Surgery of Valencia with the corresponding academic nomination. She had a postdoctoral specialization in the Biomedicine Institute-CSIC of Valencia in the line of "Characterization of genes regulated by thyroid hormone involved in differentiation". She began her teaching career as associate Professor of Pharmacology at Health Sciences university CEU Cardenal Herrera, nowadays she is professor of pharmacology. 
Title
Cited by
Year
Decision tree for early detection of cognitive impairment by community pharmacists
MT Climent, J Pardo, FJ Muñoz-Almaraz, MD Guerrero, L MorenoFrontiers in Pharmacology 9, 1232, 2018201
34
2018
Importance of increasing modifiable risk factors knowledge on alzheimer’s disease among community pharmacists and general practitioners in Spain
M Alacreu, J Pardo, M Azorín, MT Climent, V Gasull, L MorenoFrontiers in pharmacology, 860, 2019201
27
2019
Pharmacist-physician interprofessional collaboration to promote early detection of cognitive impairment: increasing diagnosis rate
H Ramos, J Pardo, R Sánchez, E Puchades, J Pérez-Tur, A Navarro, ...Frontiers in Pharmacology 12, 579489, 2021202
19
2021
¿ Conocemos todas las interacciones farmacológicas?: el transportador OATP1B1
LMM Celdran, JG Ferrando, LM RoyoFarmacéuticos comunitarios 10 (4), 29-32, 2018201
14
2018
Pharmacists’ knowledge of factors associated with dementia: the A-to-Z dementia knowledge list
H Ramos, L Moreno, M Gil, G García-Lluch, J Sendra-Lillo, M AlacreuInternational Journal of Environmental Research and Public Health 18 (19), 9934, 2021202
13
2021
A machine learning approach to design an efficient selective screening of mild cognitive impairment
FJ Muñoz-Almaraz, MT Climent, MD Guerrero, L Moreno, J PardoJoVE (Journal of Visualized Experiments), e59649, 2020202
12
2020
Developing sustainable cancer education programs: Training public health students to deliver cancer 101 in Puerto Rico
YM Rivera, L Moreno, KJ Briant, H Vélez, JC Jiménez, J Torres, ...Journal of Cancer Education 33, 128-133, 2018201
11
2018
Prescripciones potencialmente inadecuadas en pacientes ancianos polimedicados. Intervención y seguimiento del farmacéutico comunitario
O Bellver-Monzó, LM Royo, LS IbáñezFarmacéuticos comunitarios 10 (2), 5-14, 20189201
9
2018
Waist-to-height ratio and skipping breakfast are predictive factors for high blood pressure in adolescents
C Aparicio-Cercós, M Alacreu, L Salar, L Moreno RoyoScientific RepoRtS 10 (1), 16704, 2020202
5
2020
Dexamethasone Preconditioning in Cardiac Procedures Reduces Decreased Antithrombin Activity and Is Associated to Beneficial Outcomes: Role of Endothelium
V Muedra, L Moreno, V Rodilla, C Arce, F Montó, Á Blázquez, P Pérez, ...Frontiers in Pharmacology 9, 1014, 2018201
5
2018
Proyecto CRIDECO: Cribado de deterioro cognitivo en farmacia comunitaria a partir de la queja subjetiva de memoria
MTC Catalá, LM Royo, VG Molinera, RS Roy, JP TurFarmacéuticos comunitarios 10 (), 20-26, 2018201
4
2018
CRIDECO anticholinergic load scale: an updated anticholinergic burden scale. Comparison with the ACB scale in Spanish individuals with subjective memory complaints
H Ramos, L Moreno, J Pérez-Tur, C Cháfer-Pericás, G García-Lluch, ...Journal of Personalized Medicine 12 (2), 207, 2022202
4
2022
Bridging the Generational Digital Divide in the Healthcare Environment
T Lopez de Coca, L Moreno, M Alacreu, M Sebastian-MorelloJournal of Personalized Medicine 12 (8), 121, 2022202
4
2022
Differences in aortic augmentation pressure between normotensive and hypertensive subjects measured in community pharmacies in Spain
ER Sala, V Colomer, Z Perseguer, A Jordá, R Jordá, R Prats, M García, ...Journal of Hypertension 37, e09-e10, 01901
2
2019
Potenciar la lectura desde la farmacia comunitaria en personas mayores para protegerlos del deterioro cognitivo
D Feijoo Calles, E Ginesta Hervás, A Caravaca, A Miguel, M Azorín Ruiz, ...Farmacéuticos Comunitarios, vol. 11, n. 1 (enero 019)., 01901
2
2019
Addressing Psychosocial Factors in Cognitive Impairment Screening from a Holistic Perspective: The DeCo-Booklet Methodology Design and Pilot Study
C García, L Moreno, M Alacreu, FJ Muñoz, LA MartínezInternational Journal of Environmental Research and Public Health 19 (19), 1911, 0
2
2022
Evaluación de los conocimientos y habilidades de los alumnos del grado de Farmacia: Prueba ECOE (Evaluación Clínica Objetiva Estructurada)
MA Calatayud Pascual, C Balaguer Fernández, L Salar Ibáñez, ...Farmacéuticos Comunitarios, vol. 2, n. ., 2020202
1
2020